INTS CIK: 1567264

Intensity Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−5.48
FY23:
−7.21
FY24:
−15.2
FY25:
−9.23
millions USD
FY21:
0
FY22:
0
FY23:
−6.02
FY24:
6.35
FY25:
0
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
2.25
FY23:
20.5
FY24:
2.90
FY25:
18.6
millions USD
FY21:
–
FY22:
−3.23
FY23:
7.24
FY24:
−5.97
FY25:
9.33

All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data